Jasper Therapeutics (JSPR) Accumulated Depreciation (2022 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Accumulated Depreciation of $4.8 million for Q4 2025, up 26.45% year-over-year from $3.8 million in Q4 2024, and up 23.28% quarter-over-quarter from $3.9 million in Q3 2025.
Jasper Therapeutics (JSPR) Accumulated Depreciation (2022 - 2025) Analysis & Trends
Jasper Therapeutics' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 26.45% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (up 26.45% YoY), while the FY2025 annual figure was $4.8 million, up 26.45% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $4.8 million, up from $3.9 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $4.8 million in Q4 2025, with the low at $1.4 million in Q4 2022.
- The 4-year median for Accumulated Depreciation is $3.0 million (2024), against an average of $3.0 million.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation jumped 81.95% in 2023, then advanced 8.84% in 2025.
- Jasper Therapeutics' Accumulated Depreciation stood at $1.4 million in 2022, then soared by 81.95% to $2.5 million in 2023, then surged by 54.76% to $3.8 million in 2024, then grew by 26.45% to $4.8 million in 2025.
- Business Quant data shows JSPR's Accumulated Depreciation at $4.8 million in Q4 2025, $3.9 million in Q3 2025, and $3.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Jasper Therapeutics | 20.06 Mn | 20.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.81 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.35 Mn |